The alpha-trypsin inhibitor ITIH3 has been described in sepsis [38] as well as to be related to mortality in severe COVID-19 [39] and the activity of the serum paraoxonase PON1 has been shown to be predictive for 30-day mortality [40]. This evidence concerns the gene ITIH3 and COVID-19.